WEGOVY ® (semaglutide)

Wegovy (semaglutide) is a FDA-approved drug in a class of medications called glucagon-like peptide-1 receptor agonists (GLP-1s for short). Wegovy is clinically proven to help with weight loss. In a clinical trial, people who combined Wegovy with lifestyle changes lost an average of 15% of their body weight on average in 1 year.

Wegovy comes in a prefilled injection pen. You administer the injection under the skin of your stomach, thigh, or arm once a week. While a routine injection may sound intimidating, the Wegovy pen uses a tiny needle designed to minimize discomfort. You’ll also receive clear instructions on using the injection pen, and your Weightless support team can offer additional advice.

Wegovy dosing starts out low, then gradually increases over the first few months until a steady dose is reached. If prescribed, a clinician will work with you to find the schedule and dosing that’s right for you. As an example, your provider may start you out on the lowest dose, 0.25 mg injected once weekly for the first month and slowly ramp you up to the maximum dose of 2.4 mg once weekly over the course of several months. This will depend upon your specific situation and your provider’s guidance.

In the STEP 4 clinical trial, people who combined Wegovy with a healthy diet and exercise lost an average of over 4% of their body weight by eight weeks. Those who reached a steady dose of 2.4 mg per week lost an average of 10.6% of their body weight in the first 20 weeks of treatment—and over 17% of their body weight within 68 weeks. Everyone responds to Wegovy differently, and if prescribed, your Weightless support team will work with you to get the best results for you.